Clinical Trials Logo
  1. Home
  2. Cocaine Abuse
  3. NCT06045793

Comparing Efficacy & Safety Of TNX-1300 To Placebo With UC For Treatment Of Acute Cocaine Intoxication In ED Subjects (CATALYST) — CATALYST  

Cocaine Abuse Clinical Trial

Official title:
A Single-Blind, Randomized Study Comparing The Efficacy And Safety Of A Single Dose Of TNX-1300 To Placebo With Usual Care For The Treatment Of Signs And Symptoms Of Acute Cocaine Intoxication In Emergency Department Subjects (CATALYST Study)

Clinical Trial Summary

This is a Phase 2 single-blind, randomized, multicenter study to compare the efficacy and safety of a single dose of TNX-1300 to placebo with usual care in patients with acute cocaine intoxication within the emergency department setting.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06045793
Study type Interventional
Source Tonix Pharmaceuticals, Inc.
Contact Sr. Manager, Clinical Programs
Phone 203-482-3938
Email Megha.Tevar@tonixpharma.com
Status Not yet recruiting
Phase Phase 2
Start date December 11, 2023
Completion date June 4, 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT01601743 - Exercise as a Behavioral Treatment for Cocaine Dependence N/A
Completed NCT00217997 - Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals N/A
Terminated NCT00142883 - The Effects of GABA Enhancing Medications on Individuals Addicted to Cocaine - 3 N/A
Completed NCT00227903 - Therapeutic Substance Abuse Treatment in Pregnancy - 1 Phase 2
Completed NCT00842517 - Long Term Maintenance of Drug Abstinence Phase 1
Completed NCT02563769 - Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study Phase 1
Completed NCT01651377 - Pramipexole as a Treatment for Cocaine Dependence Phase 1
Recruiting NCT00439049 - Substance Abuse Pre-Treatment Screening Study
Completed NCT00249457 - Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2 N/A
Completed NCT01401270 - Prize Contingency Management for Cocaine-Dependent Methadone Patients N/A
Completed NCT00350610 - Computer-Based Training in Cognitive Behavior Therapy Phase 1
Recruiting NCT06177860 - Clinical and Atherosclerotic Characteristics of Patients With ACS Associated With Cocaine Use
Completed NCT02393599 - Study to Assess Potential Interactions Between Intravenous Cocaine and Oral Lorcaserin Phase 1
Completed NCT02141620 - n-Acetylcysteine and Cocaine Phase 0
Recruiting NCT00218023 - Medications for Stopping Cocaine Dependence and Preventing Relapse Phase 2
Completed NCT00218075 - Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence Phase 2
Recruiting NCT05857852 - Low-Intensity Focused Ultrasound for Cocaine Use Disorder N/A
Completed NCT00606801 - Galantamine Effects on Cognitive Function in Abstinent Cocaine Users N/A
Completed NCT00292123 - Combined Behavioral and Pharmacologic Treatment of Polydrug Abuse Phase 1
Completed NCT00318760 - Effect of Clonidine on Responses to Imagery Scripts Phase 1